HOME >> BIOLOGY >> NEWS
Population shifts, not storms, have caused rise in property losses

CHAMPAIGN, Ill. -- Don't blame staggering property losses of the 1990s solely on changing weather or global warming. A review of 50 years of insurance and weather records puts the blame on the movement of an ever-growing U.S. population to the coasts and major urban areas.

Large property losses in 1990-1996 raised concerns that intense storms were occurring at a greater frequency than in the past. However, after looking at insurance records and storms in the United States, "we can see there is no evidence of an upward trend in catastrophic weather events," said Stanley Changnon, chief emeritus of the Illinois State Water Survey.

"Once you take loss data and consider such factors as demographics, population, the value of money, insurance coverage and overall wealth, you can readily see that the climate is not changing, we are," he said. "The increasing losses really are the result of an increased target-at-risk."

Such factors previously were not used in the loss equation. Without accounting for these factors, loss reports have helped create "the impression of an ever-increasing weather-loss situation with time," said Changnon, a professor of geography and atmospheric sciences at the University of Illinois.

In a recently published paper in the Bulletin of the American Meteorological Association, Changnon and his colleagues showed there had been no increases in thunderstorms, hailstorms, tornadoes or hurricanes. In fact, the frequency of these storms has decreased in the past 30 years.

For the study -- parts of which also were published recently in the journals Natural Hazards and Meteorological Applications -- past losses were adjusted to current dollars to re-examine storms and insurance losses between 1950-1989 and 1990-1996.

During the two periods, the distribution of extreme storms by region stayed the same, striking most in the South, Central, Southeast and Northeast, respectively. However, the growth of losses has been greater in the
'"/>

Contact: Jim Barlow, Life Sciences Editor
b-james3@uiuc.edu
217-333-5802
University of Illinois at Urbana-Champaign
2-Aug-1999


Page: 1 2

Related biology news :

1. Addressing the Healthcare Needs of Our Aging Population with Technology
2. Talk: Population and Climate Change: Neglected Connections
3. Fogarty International Center announces new awards under International Training And Research In Population And Health Program
4. Population and climate change
5. Population-Development-Environment in Namibia: background readings
6. USGS Finds Palila Population Remaining Stable
7. UC Berkeley Conference On Population Growth And The Environment
8. Common Cannibals, A New Study Examines The Role That Intraspecific Predation Plays In Determining The Dynamics Of A Population
9. Rapid Population Growth Is Still A Problem
10. Turtle Population Apparently Threatened By Urban Sprawl, Traffic
11. Ecological Consequences Of Jasmonate-Induced Responses For Plants In Native Populations

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Population shifts not storms have caused rise property losses

(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) ... Market in India 2015-2019" report to their ... in this market is the adoption of multimodal ... one characteristic of an individual for verification and ...
(Date:12/11/2014)... Minn. , Dec. 10, 2014  Data ... physiologic monitoring, has released a new series of ... of preclinical toxicology researchers. M series, part of ... toxicologists collect the best possible physiologic data when ... Adding functional endpoints to toxicology studies has ...
(Date:12/10/2014)... 2014  Valencell, a leader in performance biometric data ... demand from its licensees for highly accurate, clinically validated ... solely coming from fitness and health sectors, but first ... wearable is only as useful as the biometric data ... driver in long-term mass consumer adoption of wearable products," ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
(Date:12/19/2014)... 2014 LayerBio is an MIT spin-off ... care. The National Eye Institute (NEI) at the National ... I SBIR grant to develop a drug-eluting intraocular lens ... common cause of vision loss in people over age ... to Dr. Ken Mandell, LayerBio’s Founder and CEO, "There ...
(Date:12/19/2014)... The empty capsules market is ... population and technological innovations in the empty capsules ... catalysing the growth of the empty capsules market. ... , Scope of Report , The report will ... entrants/smaller firms to gauge the pulse of the ...
(Date:12/19/2014)... YORK , Dec. 18, 2014 Relmada ... therapies for the treatment of chronic pain, announced the ... today. "This was a transformational year in ... promising future for our company," said Sergio Traversa ... year, we have executed on key financial, human resource ...
(Date:12/17/2014)... Ipsen Biopharmaceuticals, Inc., an affiliate ... IPSEY), today announced that Somatuline® Depot® (lanreotide) ... approved by the U.S. Food and Drug Administration ... (GEP-NETs) in adult patients with unresectable, well or ... improve progression-free survival (PFS). , “The approval of ...
Breaking Biology Technology:LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8
Cached News: